Rushnet, Inc. and heliosDX Launch AutoUA(R) Testing to Enhance Patient Care and Help Prevent Kidney Disease Among Other Conditions including UTI

Author's Avatar
Jul 11, 2022

ALPHARETTA, GA / ACCESSWIRE / July 11, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce that it has joined efforts with Sciteck® Diagnostics by adopting its AutoUA® reagent system to combat against Kidney Disease and other ailments, particularly urinary tract infections or UTI.